Immunogenic compositions and uses thereof

Details Immunogenic compositions and uses thereof Immunogenic compositions and uses thereof

1999-09-14

2009-08-18

Minnifield, N. M (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

C424S172100, C424S184100, C424S265100, C424S269100, C424S272100, C514S002600, C514S007600, C514S008100, C514S012200, C514S054000

Reexamination Certificate

active

07575755

ABSTRACT:
The present invention relates generally to a method of eliciting or otherwise inducing an effective immune response to a micro-organism and compositions for use therein. More particularly, the present invention relates to a method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as “GPI”) inositolglycan domain or its derivatives. Even more particularly, the present invention contemplates an immunogenic composition comprising thePlasmodium falciparumGPI inositolglycan domain or its derivatives. The present invention is useful, inter alia, as a prophylactic and/or therapeutic treatment for disease conditions such as, for example, infection by parasites and in particular infection byPlasmodiumspecies.

REFERENCES:
patent: 5726166 (1998-03-01), Playfair et al.
patent: 5968742 (1999-10-01), Bandman et al.
patent: 6113917 (2000-09-01), Fasel et al.
patent: 6551586 (2003-04-01), Davidson et al.
patent: 2006/0089330 (2006-04-01), Seeberger et al.
patent: 2006/0147476 (2006-07-01), Schofield
patent: 2008/0044428 (2008-02-01), Schofield
patent: 65674/94 (1994-12-01), None
patent: 4311580 (1994-08-01), None
patent: WO 97/10249 (1997-03-01), None
patent: WO 0024406 (2000-03-01), None
patent: WO 2004/011026 (2004-02-01), None
patent: WO 2005/120519 (2005-12-01), None
Schofield et al, J. Immunology 156:1886-96, 1996.
Tachado et al, PNAS, USA; 94: 4022-27, 1997.
Richardson et al, Insect Molecular Biology 1/3: 139-147, 1993.
Tachado et al, J. Immunology 156:1897-1907, 1996.
Tachado et al, BBRC 205/2:984-991, 1994.
Eckert et al, European J. Cell Biol 69/Suppl 42:148, Abstract# 443, 1996.
Moran et al, JCB, 125/2: 333-343, 1994.
Schofield et al, Nature 418:785-789, 2002.
Campos et al, J Immunology, 167:416-423, 2001.
Delorenzi et al, Infection and Immunity 70/8:4510-4522, 2002.
Schofield In: Paroxysmal Nocturnal Hemoglobimeria and the Glycosylphosphatidylinositol-lined Proteins Editor Young et al pp. 179-198, 2000.
Azzouz et al, Glycobiology, 10/2:177-183, 2000.
Schofield et al, Science, 283:225-229, 1999.
Tachado et al, Parasite Immunology 21:609617, 1999.
Garg et al, JBC, 272/19:12482-12491, 1997.
Zinecker et al, Indian J. Biochemistry and Biophysics, 34:105-109, 1997.
Sauma et al, Molecular and Biochemical Parasitology 38:199-210, 1990.
Tiede et al, Biol. Chem. 380:503-523, 1999.
Gazzinelli et al, Ciencia e Cultura 51(5/6):411-428, 1999.
Kedees et al, European J. Cell Biology 79:52-61, 2000.
Gowda et al, Parasitology Today, 1999, 15/4:174-152.
Ramasamy, BBA, 1998, 1406-10-27.
Clark et al, Parasitology Today, 2000, 16/10:451-454.
Gowda, Microbes and Infection, 2002, 4:983-990.
Fanning et al, Vaccine, 2003, 21:3228-3235.
Clark et al, Pharmacology and Therapeutics, 2003, 99:221-260.
Dekker et al, Molecular and Biochemical Parasitology, 2004, 137:143-149.
Lu et al, Tetrahedron Letters, 2004, 45:879-882.
Bruna-Romeo et al, Vaccine, 2004, 22:3575-3584.
Ropert et al, Current Opinino in Microbiology, 2000, 3:395-403.
Butikofer et al, FASEBJ, 2001, 15:545-548.
Glaser, Current Opinion in Structural Biology, 1993, 3/4:475-481 abstract only.
Fujita et al, BBA, Mar. 2008, 1780/3:410-420 Abstract only.
Debierre-Grockiego et al, Infection and Immunity, Oct. 2006, 74/10:5487-5496.
Streipen et al, J. Mol. Biol., 1997, 266:797-813.
Paulick et al, J. Am. Chem. Soc., 2007, 129:11543-11550.
Schofield et al., “Signal transduction in host cells mediated by glycosylphosphatidylinositols of the parasitic protozoa, or why do the parasitic protozoa have so many GPI molecules?,”Brazilian J. Med. Biol. Res. (1994), vol. 27, pp. 249-254.
McConville et al., “The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes,”Biochem. J. (1993), vol. 294, pp. 305-324, Great Britain.
Elhay et al., “Lipophosphoglycan expression and virulence in Ricin-resistant variants of leishmania major,”Molecular and Biochemical Parasitology(1990), vol. 40, pp. 255-268, Elsevier Scinece Publishers B.V. (Biomedical Division).
Misek et al., “An Inositol Phosphate Glycan Derived from aTrypanosoma bruceiGlycosyl-Phosphatidylinositol Mimics some of the Metabolic Actions of Insulin,”The Journal of Biological Chemistry(Aug. 15, 1992), vol. 267, No. 23, pp. 16266 16273, The American Society for Biochemistry and Molecular Biology, Inc.
Gerold et al., “Structual analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 ofPlasmodium falciparum,” Molecular and Biochemical Parasitology(1996), vol. 75, pp. 131-143, Elsevier Science B.V.
Richardson et al., “Native and baculovirus-expressed forms of the immuno-protective protein BM86 fromBoophilus microplusare anchored to the cell membrane by a glycosyl-phosphatidyl inositol linkage,”Insect Molecular Biology(1993), vol. 1, No. 3, pp. 139-147.
Schofield et al., “Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa,”Immunology and Cell Biology(1996), vol. 74, pp. 555-563.
Scholfield et al., “Signal Transduction in Host Cells by a Glycosylphosphatidylinositol Toxin of Malaria Parasites,”J. Exp. Med. ( Jan. 1993), vol. 177, pp. 145-153, The Rockefeller University Press.
Tachado et al., “Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: Activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties,”Proc. Natl. Acad. Sci. (Apr. 1997), vol. 94, pp. 4022-4027, The National Academy of Sciences of the USA.
Reymond et al., “Anchoring of an ImmunogenicPlasmodium falciparumCircumsporozoite Protein on the Surface ofDictyostelium discoideum,” The Journal of Biological Chemistry(1995), vol. 270, No. 21, pp. 12941-12947.
Romero G. et al., “Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells”,Proc. Natl. Acas. Sci. USA87:1476-1480 (1990).
Schenkman S. et al., “Glycophosphatidylinositol-anchored proteins inmetacyclic trypomastigotes ofTrypanosoma cruzi”, Molecular and Biochemical Parasitology 29:141-152 (1988).
Galili U., “Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody”,Sprigner Semin Immunopathol 15:155-171 (1993).
Dumitriu, S., “Polysaccharides In Medicinal Applications”, Marcel Dekker, Inc. pp. 277-291 (1996).

Affiliated with

Also associated with

Rating

Immunogenic compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic compositions and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4122213